Cambridge Healthtech Advisors - Successful Outsourcing of Pharmaceutical R&D: Trends and Strategies Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast, Inflammatory Disease Therapeutics: Pipelines and Competitive Dynamics , 2015: Strategic Considerations for the U.S. Pharmaceutical Industry, Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches, Toxicogenomics and Predictive Toxicology: Market and Business Outlook, Model Animal Systems Emerging Applications and Commercial Opportunities in Drug Discovery and Development, Hematological Cancer Therapeutics - Pipelines and Competition, Cardiovascular Diagnostics - Key Developments in Technologies and Markets, Biomarkers in Clinical Development: Implications for Personalized Medicine and Streamlining R&D, Pharmaceutical R&D Productivity - The Path to Innovation Microarrays: Technologies, Applications, Markets, Clinical Genomics Molecular Imaging Comes of Age - Applications and Impacts in Discovery, Clinical Trials, and Medical Practice, Powering Discovery through Target Evaluation - Moving Beyond the Validation Paradigm, High-Content Analysis Market Outlook, Proteins: Selection, Synthesis, and Purification Strategies for Optimizing Drug Discovery, New Directions in Monoclonal Antibodies: Technologies, Markets, Competition, Pharmacodiagnostics - Technologies, Competition, and Market Models Nutrigenomics - Impacts on Markets, Diets, and Health, Chronic Obstructive Pulmonary Disease (COPD) Therapeutics

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

BioReports - Cambridge Healthtech - Insight Pharma Report